In conclusion, carrying a DNMT3A- and/or TET2-CHIP-driver mutation is an independent prognostic risk factor for increased long-term mortality in patients with severe aortic stenosis even after successful removal of the stenotic valve by TAVR. The gene discussed is TET2; the disease is aortic stenosis.